UNO Medical Group, through its wholly-owned operations and strategic investments, is to build an eco-system to better serve practitioners, providers and patients in the medical industry. At present, UNO Medical Group operates its business in China, Singapore and Indonesia.


UNO e-Clinic is an online medical technology healthcare platform adjunct to UNO Clinic and other community clinics. The on-line medical technology platform is integrated with EMR, Data Analytics, Medical AI solutions, VSM, VR etc. to enable effective online consultation and patients’ care.

In addition, it offers medical practitioners to publish & share their clinical experiences, achievements to each other online and for CME purpose at their convenience. Enabling sponsorships from commercial institutions in the medical industry to advance specific medical knowledge to both the medical practitioners and patients.

UNO e-Clinic is a wholly-owned operating unit of UNO medical group.


UNO Clinic is a physical medical clinics under the UNO Medical Group, which features intelligent technology and precision diagnosis for treatment, aiming to create special outpatient specialties to solve intractable diseases and fulfill medical needs within the community. The primary services provided in UNO Clinic are diagnosis and treatment for common diseases, frequently-occurring diseases, seasonal diseases, and chronic diseases, as well as disease prevention, health management consulting. The first brand flagship clinic - UNO Clinic (Shenzhen. Nanshan) has commenced business operation since 2019 at a floor area of nearly 1,000 square meters.

UNO Clinic is a wholly-owned operating unit of UNO medical group.


Shanggong is a medical data analytics (AI Algorithm) company in the medical service in China, having fully curated, quality controlled approximately 700,000 retinal images of diabetic patients in China, which forms a retinopathy big data that enables AI Algorithm to perform its diagnosis. The AI Algorithm can screen retinal images of patients and detect diabetic retinopathy.

The AI Algorithm of Shanggong is some form of automated detection which could make the diagnosis more efficient and reliable, and could be especially useful in regions where the required expertise is scarce. The AI Algorithm has been deployed and is being used in more than 300 hospitals in China.

Shanggong is a strategic investment enterprise of UNO medical group.



UNO Technologies is an Asia Focused Health-Tech business with its HQ in Singapore. Established in 2015, We have provided our clients in the healthcare sector across the region with intelligent, scalable clinic management and electronic medical record systems.

Our system provides accurate, up-to-date and actionable data to help physicians, clinics and individuals take smarter decisions. It also helps clinic administrators to run and optimize their business with intelligent tools and efficient processes.

At UNO Technologies, we believe in leveraging AI (artificial intelligence) to develop solutions that will transform the way healthcare professionals and companies engage both their patients and external stakeholders. With data analytics tools, a series of healthcare solutions will proliferate through UNO’s open API (application programming interface) architecture, to seamlessly integrate with other web-based solutions, so as to evolve into a web-based ecosystem of solutions for the healthcare industry at large.

UNO Technologies is a wholly-owned operating unit of UNO medical group.



YesDok is an ehealth service that is reachable through mobile platform which is very powerful and easy to use. Penetrating 17504 islands and 260 million users in Indonesia.

YesDok doctor-partners are those that are registered on Indonesian Medical Council. They are committed in being preventive, promotive and delivering quality health information.

YesDok is a strategic investment enterprise of UNO medical group.